Thorough intraoperative analysis of breast sentinel lymph node biopsies: Histologic and immunohistochemical findings

Surgery

Volumn 135, Issue 3, 2004, Pages 248-254

  D'Errico, Antonia ^b   Grassigli, Alberto ^b   Gruppioni, Elisa ^b   Fiorentino, Michelangelo ^b   Corti, Barbara ^b   Gabusi, Elena ^b   Morselli Labate, Antonio Maria ^b   Grigioni, Walter Franco ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKERATIN;

AXILLARY LYMPH NODE; BREAST CARCINOMA; CANCER GRADING; CANCER INVASION; CANCER SCREENING; CORRELATION ANALYSIS; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; INTRAOPERATIVE PERIOD; LYMPH NODE METASTASIS; LYMPHANGITIS; MALIGNANT TRANSFORMATION; PRIORITY JOURNAL; REVIEW; SENTINEL LYMPH NODE BIOPSY; TISSUE FIXATION; TISSUE SECTION; TUMOR ASSOCIATED LEUKOCYTE;

EID: 1542380079     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.surg.2003.10.002     Document Type: Article

References (34)

1. Schwartz GF, Giuliano AE, Veronesi U, and the Consensus Conference Committee. Proceedings of the Consensus Conference on the Role of Sentinel Lymph Node Biopsy in Carcinoma of the Breast, April 19 to 22, 2001, Philadelphia, Pennsylvania. Hum Pathol 2002;33:579-89.
2. Veronesi U, Paganelli G, Galimberti V, Viale G, Zurrida S, Bedoni M, et al. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymphnodes. Lancet 1997;349:1864-7.
3. Krag D, Weaver D, Ashikaga T, Moffat F, Klimberg VS, Shriver C, et al. The sentinel node in breast cancer. N Engl J Med 1998;339:941-6.
4. Borgstein PJ, Pijpers R, Comans EF, van Diest PJ, Boom RP, Meijer S. Sentinel lymph node biopsy in breast cancer: guidelines and pitfalls of lymphoscintigraphy and gamma probe detection. J Am Coll Surg 1998;186:275-83.
5. Fisher B, Wolmark N, Bauer M, Redmond C, Gebhardt M. The accuracy of clinical nodal staging and of limited axillary dissection as a determinant of histologic nodal status in carcinoma of the breast. Surg Gynecol Obstet 1981;152: 765-72.
6. Giuliano A, Dale PS, Turner RR, Morton DL, Evans SW, Krasne DL. Improved axillary staging of breast cancer with sentinel lymphadenectomy. Ann Surg 1995;222:394-401.
7. Noguchi M, Tsugawa K, Bando E, Kawahara F, Miwa K, Yokojama K, et al. Sentinel lymhadenectomy in breast cancer: identification of sentinel lymph node and detection of metastases. Breast Cancer Res Treat 1999;53:97-104.
8. Carter C, Allen C, Henson D. Relation of tumor size, lymph node status and survival in 24,740 breast cancer cases. Cancer 1989;63:181-7.
9. Siegel B, Mayzel K, Love S. Level I and II axillary dissection in the treatment of early-stage breast cancer. An analysis of 259 consecutive patients. Arch Surg 1990;125:1144-7.
10. Kjaergaard J, Blichert-Toft M, Andersen JA, Rank F, Pedersen BV. Probability of false negative nodal status in conjunction with partial axillary dissection in breast cancer. Br J Surg 1985;72:365-7.
11. Brenin DR, Morrow M, Moughan J, Owen JB, Wilson JF, Winchester DP. Management of axillary lymph nodes in breast cancer: a national pattern of care study of 17,151 patients. Ann Surg 1999;230:686-91.
12. Viale G, Bosari S, Mazzarol G, Galimberti V, Luini A, Veronesi P, et al. Intraoperative examination of axillary sentinel lymph nodes in breast carcinoma patients. Cancer 1999;85:2433-8.
13. Viale G, Maiorano E, Mazzarol G, Zurrida S, Galimberti V, Luini A, et al. Histologic detection and clinical implications of micrometastases in axillary sentinel lymph nodes for patients with breast carcinoma. Cancer 2001;92:1378-84.
14. Yared MA, Middleton LP, Smith TL, Kim HW, Ross MI, Hunt KK, et al. Recommendations for sentinel lymph node processing in breast cancer. Am J Surg Pathol 2002;26: 377-82.
15. Silverberg SG. Sentinel node processing. Am J Surg Pathol 2002;26:383-5.
16. van Diest PJ, Torrenga H, Borgstein PJ, Pijpers R, Bleichrodt RP, Rahusen FD, et al. Reliability of intraoperative frozen section and imprint cytological investigation of sentinel lymph nodes in breast cancer. Histopathology 1999;35:14-8.
17. Turner RR, Hansen NM, Stern SL, Giuliano AE. Intraoperative examination of the sentinel lymph node for breast carcinoma staging. Am J Clin Pathol 1999;112:627-34.
18. Turner RR, Ollila DW, Stern S, Giuliano AE. Optimal histopathologic examination of the sentinel lymph node for breast carcinoma staging. Am J Surg Pathol 1999;23:263-7.
19. Motomura K, Inaji H, Komoike Y, Kasugai T, Nagumo S, Noguchi S, et al. Intraoperative sentinel lymph node examination by imprint cytology and frozen sectioning during breast surgery. Br J Surg 2000;87:597-601.
20. Veronesi U, Zurrida S, Mazzarol G, Viale G. Estensive frozen section examination of axillary sentinel nodes to determine selective axillary dissection. World J Surg 2001;25: 806-8.
21. Tanis PJ, Boom RP, Koops HS, Faneyte IF, Peterse JL, Nieweg OE, et al. Frozen section investigation of sentinel node in malignant melanoma and breast cancer. Ann Surg Oncol 2001;8:222-6.
22. Associations of Directors of Anatomic and Surgical Pathology. ADASP recommendations for processing and reporting lymph node specimens submitted for evaluation of metastatic disease. Am J Surg Pathol 2001;25:961-3.
23. Smillie T, Hayashi A, Rusnak C, Dunlop W, Donald J, van der Westhuizen N. Evaluation of feasibility and accuracy of sentinel node biopsy in early breast cancer. Am J Surg 2001;181:427-30.
24. Goldhirsch A, Glick JH, Gelber RD, Coates AS, Senn HJ. Meeting highlights: International Consensus Panel on the Treatment of Primary Breast Cancer. Seventh International Conference on Adjuvant Therapy of Primary Breast Cancer. J Clin Oncol 2001;19:3817-27.
25. Siegel S. Non-parametric statistics for the behavioral sciences. New York: McGraw-Hill, 1956.
26. Norusis MJ. SPSS Inc. SPSS/PC+ Base System User's Guide, Version 5.0. Chicago: SPSS. 1992.
27. Dickson RB, Lippman ME. Cancer of the breast. In: DeVita VT, Hellman S, Rosemberg SA. Cancer. Principles and practice of oncology. 6th ed. Philadelphia: Lippincott Williams and Wilkins; 2001. p. 1633-712.
28. Schrenk P, Hatzl-Griesenhofer M, Shamiyed A, Waynad W. Follow-up of sentinel node negative breast cancer patients without axillary lymph node dissection. J Surg Oncol 2001;77:165-70.
29. Fitzgibbons PL, Page DL, Weaver D, Thor AD, Allred DC, Clark GM, et al. Prognostic factors in breast cancer: College of American Pathologists consensus statement 1999. Arch Pathol Lab Med 2000;124:966-78.
30. Tjan-Heijnen VCG, Bult P, de Widt-Levert LM, Ruers TJ, Beex LVAM. Micro-metastases in axillary lymph nodes: an increasing classification and treatment dilemma in breast cancer due to the introduction of the sentinel lymph node procedure. Br Cancer Res Treat 2001;70:81-8.
31. Guinebretiere JM, Contesso G. "Micrometases": the pathologist's point of view. Bull Cancer 2001;88:549-50, 555-60.
32. Klauber-DeMore N, Van Zee KJ, Linkov I, Borgen PI, Gerald WL. Biological behavior of human breast cancer micrometastases. Clin Cancer Res 2001;7:2434-9.
33. Braun S, Pantel K. Prognostic significance of micrometastatic bone marrow involvement. Breast Cancer Res Treat 1998;52:201-16.
34. Cummings MC, Walsh MD, Hohhn BG, Bennett IC, Wright RG, McGuckin MA. Occult axillary lymph node metastases in breast cancer do matter, results of 10-year survival analysis. Am J Surg Pathol 2002;26:1286-95.